InsiderClue
Stocks · Health care · Services-Medical Laboratories

Advanced Biomed Inc.

ADVB Clue Score29
United States Fiscal year ends June CIK 0001941029
$5.28 -0.66% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $5.28 +1,146.16% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 6 Mar 2025. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Net income
Fiscal year 2024Net income−2.8EPS, diluted−0.14Fiscal year 2025Net income−3.3EPS, diluted−0.16
FY2024FY2025
Net income −2.8 −3.3
Growth
EPS, diluted −0.14 −0.16
Growth

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2024Operating cash flow−2.1Capital expenditure−0.1Free cash flow−2.2Fiscal year 2025Operating cash flow−5.8Capital expenditure−0.0Free cash flow−5.9
FY2024FY2025
Operating cash flow −2.1 −5.8
Capital expenditure −0.1 −0.0
Free cash flow −2.2 −5.9
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2024Cash2.6Shareholders’ equity1.7Fiscal year 2025Cash2.9Shareholders’ equity3.5
FY2024FY2025
Cash 2.6 2.9
Shareholders’ equity 1.7 3.5

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending June, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2024 30 Jun 2024 FY2025 30 Jun 2025
Revenue and profit
0.9 0.9
1.7 2.1
−2.8 −3.3
−2.8 −3.3
Growth
Per share
−0.14 −0.16
−0.14 −0.16
Growth
20.0 20.5
20.0 20.5
Growth +2.6%

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 2 of 2 years on file.